本报告对2022年转化医学最佳医院80强的地区分布和部分排名指标进行分析,发现入围机构数最多的是上海和北京(各17家),其次是广东(8家),80强医院所在地区有经济发展较繁荣、医疗器械或药品厂商多、高质量医学院校多等特点,可以为医院科研人才培养、项目合作、科研成果转化等提供支持。从排名指标来看,医院发明专利授权数呈逐年增长趋势;高质量人才配备、高难度研究项目和成果产出随榜单名次变化显现出较大差异,说明80强医院之间转化医学研究能力差距较大。80强医院基本都是高校附属医院,与高校在转化医学研究平台搭建、课题合作等方面交流密切。本报告列举医院转化医学研究的典型案例,以期为医院、高校和企业提供合作模式参考,整合多方资源与优势,提高研究成果产品化率,为改善人民健康服务。
<<This report analyzes the regional distribution and some ranking indicators of the top 80 hospitals for translational Medicine in 2022. It found that the landing is the maximum number of institutions in Shanghai and Beijing (17),followed by Guangdong (8),80-strong hospital region have a more prosperous economic development,medical equipment,or drug manufacturer,high quality medical schools and other characteristics,can for the hospital scientific research and personnel training,project cooperation,support transformation of scientific research achievements,etc. From the ranking index,the number of hospital invention patent authorization increased in recent three years. High-quality personnel allocation,difficult research projects and results showed great differences with the ranking of the list,indicating a large gap in translational medicine research capacity among the top 80 hospitals. Most of the top 80 hospitals are affiliated to universities and have close exchanges with universities in terms of translational medicine research platform construction and project cooperation. This report lists typical cases of translational medicine research in hospitals,in order to provide reference for the cooperation model of hospitals,universities and enterprises,integrate multiple resources and advantages,improve the commercialization rate of research results,and apply them to the clinical benefit of patients.
<<